Pfizer Inc. (NYSE:PFE) shares traded 0.26% higher at $27.43 on Wall Street last session.
PFE stock price is now -0.34% away from the 50-day moving average and -13.86% away from the 200-day moving average. The market capitalization of the company currently stands at $154.89B.
On February 23, 2024, Guggenheim recently initiated its ‘Buy’ rating on the stock quoting a target price of $36, while ‘TD Cowen’ rates the stock as ‘Market Perform’
In other news, Gottlieb Scott, Director bought 3,000 shares of the company’s stock on Dec 15 ’23. The stock was bought for $79,401 at an average price of $26.47. Upon completion of the transaction, the Director now directly owns 9,000 shares in the company, valued at $0.25 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 08 ’23, Director Gottlieb Scott bought 1,000 shares of the business’s stock. A total of $38,580 was incurred on buying the stock at an average price of $38.58. This leaves the insider owning 6,000 shares of the company worth $0.16 million. A total of 0.04% of the company’s stock is owned by insiders.
During the past 12 months, Pfizer Inc. has had a low of $25.61 and a high of $42.22. As of last week, the company has a debt-to-equity ratio of 0.84, a current ratio of 0.91, and a quick ratio of 0.69. The fifty day moving average price for PFE is $27.52 and a two-hundred day moving average price translates $31.84 for the stock.
The latest earnings results from Pfizer Inc. (NYSE: PFE) was released for Dec, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $0.09, beating analysts’ expectations of -$0.2 by 0.29. This compares to $0.86 EPS in the same period last year. The net profit margin was 3.65% and return on equity was 2.31% for PFE. The company reported revenue of $14.25 billion for the quarter, compared to $24.29 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -41.34 percent. For the current quarter, analysts expect PFE to generate $13.07B in revenue.
